Neuroendocrine Tumors

"Neuroendocrine Tumors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Descriptor ID	D018358
MeSH Number(s)	C04.557.465.625.650 C04.557.580.625.650
Concept/Terms	Neuroendocrine Tumors Neuroendocrine Tumors Neuroendocrine Tumor Tumor, Neuroendocrine Tumors, Neuroendocrine

Below are MeSH descriptors whose meaning is more general than "Neuroendocrine Tumors".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Germ Cell and Embryonal [C04.557.465]
Neuroectodermal Tumors [C04.557.465.625]
Neuroendocrine Tumors [C04.557.465.625.650]
Neoplasms, Nerve Tissue [C04.557.580]
Neuroectodermal Tumors [C04.557.580.625]
Neuroendocrine Tumors [C04.557.580.625.650]

Below are MeSH descriptors whose meaning is related to "Neuroendocrine Tumors".

Below are MeSH descriptors whose meaning is more specific than "Neuroendocrine Tumors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neuroendocrine Tumors" by people in this website by year, and whether "Neuroendocrine Tumors" was a major or minor topic of these publications.

Bar chart showing 32 publications over 17 distinct years, with a maximum of 4 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2004	2	0	2
2005	0	1	1
2006	1	0	1
2007	3	0	3
2009	1	1	2
2010	1	0	1
2011	2	0	2
2012	3	1	4
2013	2	0	2
2015	1	0	1
2016	3	0	3
2021	3	0	3
2022	3	0	3
2023	1	0	1
2024	0	1	1

Below are the most recent publications written about "Neuroendocrine Tumors" by people in Profiles.

Desai P, Takahashi N, Kumar R, Nichols S, Malin J, Hunt A, Schultz C, Cao Y, Tillo D, Nousome D, Chauhan L, Sciuto L, Jordan K, Rajapakse V, Tandon M, Lissa D, Zhang Y, Kumar S, Pongor L, Singh A, Schroder B, Sharma AK, Chang T, Vilimas R, Pinkiert D, Graham C, Butcher D, Warner A, Sebastian R, Mahon M, Baker K, Cheng J, Berger A, Lake R, Abel M, Krishnamurthy M, Chrisafis G, Fitzgerald P, Nirula M, Goyal S, Atkinson D, Bateman NW, Abulez T, Nair G, Apolo A, Guha U, Karim B, El Meskini R, Ohler ZW, Jolly MK, Schaffer A, Ruppin E, Kleiner D, Miettinen M, Brown GT, Hewitt S, Conrads T, Thomas A. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities. Cell Rep Med. 2024 Jun 18; 5(6):101610.

View in: PubMed
Paterson C, Perrotti G, Mushtaq B, Heilman J, Fassler S. Mixed Adeno-Neuroendocrine Neoplasms: Two Cases, One Institution. CRSLS. 2023 Oct-Dec; 10(4).

View in: PubMed
Lewandowski RJ, Toskich BB, Brown DB, El-Haddad G, Padia SA. Role of Radioembolization in Metastatic Neuroendocrine Tumors. Cardiovasc Intervent Radiol. 2022 Nov; 45(11):1590-1598.

View in: PubMed
Russ DH, Barta JA, Evans NR, Stapp RT, Kane GC. Volume Doubling Time of Pulmonary Carcinoid Tumors Measured by Computed Tomography. Clin Lung Cancer. 2022 11; 23(7):e453-e459.

View in: PubMed
Mouchtouris N, Smit RD, Piper K, Prashant G, Evans JJ, Karsy M. A review of multiomics platforms in pituitary adenoma pathogenesis. Front Biosci (Landmark Ed). 2022 03 04; 27(3):77.

View in: PubMed
Qu S, Fetsch P, Thomas A, Pommier Y, Schrump DS, Miettinen MM, Chen H. Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers. J Thorac Oncol. 2022 01; 17(1):141-153.

View in: PubMed
Ruff SM, Standring O, Wu G, Levy A, Anantha S, Newman E, Karpeh MS, Nealon W, Deutsch GB, Weiss MJ, DePeralta DK. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology. Ann Surg Oncol. 2021 Dec; 28(13):8318-8328.

View in: PubMed
MacFarlane AW, Yeung HM, Alpaugh RK, Dulaimi E, Engstrom PF, Dasari A, Campbell KS, Vijayvergia N. Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms. Cancer Immunol Immunother. 2021 Jul; 70(7):1893-1906.

View in: PubMed
Parmer M, Milan S, Torabi A. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid. Int J Surg Pathol. 2017 Apr; 25(2):191-194.

View in: PubMed
Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. Br J Cancer. 2016 08 23; 115(5):564-70.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement